Henry Schein saw the highest growth of 3.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Henry Schein‘s patent filings and grants. Buy the databook here.
Henry Schein has been focused on protecting inventions in European Patent Office(EPO) with five publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 30% filings and 33% grants. The European Patent Office(EPO), United States(US), France(FR), and Germany(DE) patent Office are among the top ten patent offices where Henry Schein is filings its patents. Among the top granted patent authorities, Henry Schein has 33% of its grants in European Patent Office(EPO), 33% in United States(US) and 33% in Poland(PL).
Johnson & Johnson and Globus Medical could be the strongest competitors for Henry Schein
Patents related to 3d printing and cell & gene therapy lead Henry Schein's portfolio
Henry Schein has the highest number of patents in 3d printing followed by, cell & gene therapy. For 3d printing, nearly 67% of patents were filed and no patents were granted in Q2 2024.
Dental devices related patents lead Henry Schein portfolio followed by orthopedic devices, and packaging
Henry Schein has highest number of patents in dental devices followed by orthopedic devices, packaging, dental implants, and sterilisation. For dental devices, nearly 64% of patents were filed and 40% of patents were granted in Q2 2024.
For comprehensive analysis of Henry Schein's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.